Trademark: 79190853
Word
LITYNDA
Status
Dead
Status Code
404
Status Date
Monday, June 13, 2022
Serial Number
79190853
Registration Number
5153313
Registration Date
Tuesday, March 7, 2017
Mark Type
4000
Filing Date
Monday, May 23, 2016
Published for Opposition
Tuesday, December 20, 2016
Cancellation Date
Monday, June 13, 2022

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jan 8, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Jan 8, 2023
Death Of International Registration
Mar 7, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 8, 2017
Final Decision Transaction Processed By Ib
Jun 20, 2017
Final Disposition Notice Sent To Ib
Jun 20, 2017
Final Disposition Processed
Jun 7, 2017
Final Disposition Notice Created, To Be Sent To Ib
Mar 7, 2017
Registered-Principal Register
Dec 20, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2016
Published For Opposition
Nov 30, 2016
Notification Of Notice Of Publication E-Mailed
Nov 7, 2016
Approved For Pub - Principal Register
Nov 5, 2016
Teas/Email Correspondence Entered
Nov 4, 2016
Correspondence Received In Law Office
Nov 4, 2016
Teas Response To Office Action Received
Oct 26, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 26, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 2, 2016
Refusal Processed By Ib
Sep 15, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Sep 15, 2016
Refusal Processed By Mpu
Sep 14, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Sep 13, 2016
Non-Final Action Written
Sep 10, 2016
Application Filing Receipt Mailed
Sep 8, 2016
Assigned To Examiner
Sep 6, 2016
New Application Office Supplied Data Entered In Tram
Aug 26, 2016
Limitation From Original Application Entered
Aug 25, 2016
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24